Risk factors for severe respiratory syncytial virus-associated respiratory tract infection in a high HIV prevalence setting, South Africa, 2012 – 2018

期刊论文
出版模式：

开放获取
发表日期：

2024年10月9日

查看全文

Jocelyn Moyes,
Stefano Tempia,
Sibongile Walaza,
Adam L. Cohen,
Florette Treurnicht,
Orienka Hellferscee,
Nicole Wolter,
Anne von Gottberg,
Halima Dawood,
Ebrahim Variava,
Kathleen Kahn,
Shabir A. Madhi,
Cheryl Cohen

摘要

Background

Identifying risk factors for respiratory syncytial virus (RSV)–associated severe acute respiratory illness (SARI) will assist with targeting vaccine interventions.

Methods

Using surveillance data from South Africa (2012–2018), we compared the characteristics of individuals with RSV-associated influenza-like illness (ILI) (reference group) to those with RSV-associated SARI to describe factors associated with SARI using a multivariable analysis.

Results

RSV was detected in 6% (483/7792) of ILI cases and 15% (844/5672) of SARI cases. Factors associated with SARI in children included age < 2 months, compared to age 2–4 years (adjusted odds ratio (aOR) 54.4; 95% confidence interval (CI) 23.5–125.8), malnutrition (aOR 1.9; 95% CI 1.2–3.2), prematurity (aOR 2.4; 95% CI 1.3–4.6) and living with HIV (LWH) (aOR 22.5; 95% CI 2.9–174.3). In individuals ≥ 5 years, factors associated with SARI included age ≥ 65 years compared to age 5–24 years (aOR 10.7; 95% CI 1.1–107.5), symptom duration ≥ 5 days (aOR 2.7; 95% CI 1.1–6.3), underlying illness (aOR 2.7; 95% CI 1.5–26.1) and LWH (aOR 16.8, 95% CI: 4.8–58.2).

Conclusion

Individuals at the extremes of age and those with identified risk factors might benefit most from RSV prevention interventions.

Clinical trial number

Not applicable, this is not a clinical trial.